Surgical Microscopes Market 2017-2025 Revenue, Opportunity, Segment and Key Trends

A surgical microscope or operating microscope is an electrically or mechanically operated optical microscope designed specifically to perform microsurgeries in a surgical setting. It provides magnification (typically ranging from 4x–40x), illuminated image, and stereoscopic vision of the surgical area. Surgical microscopes mainly offer a strain-free procedure to surgeons. Their components are designed to sterilize or disinfect easily to avoid cross infection. The modern operating or surgical microscope can be placed on a surface such as a table top, mounted on a stand, or worn by the surgeon on the head. In a surgical suite with limited space, it can be hung on the wall or ceiling to conserve floor space. It enables students, staff, as well as the patient to gain a better view of the target site, along with the surgeon.

Obtain Report Details: http://www.transparencymarketresearch.com/surgical-microscopes-market.html

The global surgical microscope market is expected to develop substantially due to the rising prevalence of chronic diseases and adoption of microsurgeries or minimally invasive surgeries. Demand for them is predicted to drive the market for surgical microscopes as they play a critical role in these surgeries. The geriatric population is highly susceptible to several chronic disorders and age-related problems, which is likely to aid the expansion of the market. Furthermore, advancements in health care infrastructure and research & development in life sciences are predicted to drive the market. Rapid technological advancements in surgical microscopes regarding visibility, portability, stability, adoption of fluorescence image-guided surgery (FIGS), and addition of innovative features such as the red reflex stability, augmented microscopy, and wide angle view are anticipated to propel the market during the forecast period.

However, the high cost of the microscope leading to its low acceptance may restrain the market in some regions, apart from the heavy custom duties on medical instruments and excise tax implementations by the U.S. government. The dearth of skilled professionals and inadequate technical knowledge may lead to sluggish development of the global surgical microscope market.
The market can be segmented on the basis of application into the following categories: ophthalmic surgeries, neurosurgery, ENT surgeries, plastic & reconstructive surgery, spine surgery, dentistry, gynecology (also colposcopes for diagnostics in gynecologic treatments), and urology. Ophthalmology is the dominant segment due to growing concerns over vision & eyesight, increasing prevalence of eye disorders, and rising population opting for ophthalmology surgeries globally. The ENT segment is projected to advance significantly owing to the mounting preference for minimally invasive surgeries for ENT, high prevalence of disorders such as sinusitis, and supportive reimbursement plans. In terms of end-user, the global surgical microscope market can be divided into the following groups: hospitals, specialty clinics, and ambulatory surgical centers.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23702

Geographically, the market can be distributed over five major regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the surgical microscope market, owing to the sophisticated health care services and supportive reimbursement policies for medical treatments enabling greater usage of the instrument in the region. Moreover, the rising incidence of chronic diseases and higher adoption of minimally invasive surgeries play a role too. Asia Pacific is estimated to expand rapidly on account of the increasing geriatric population, advancements in health care facilities, and supportive medical reimbursement programs in emerging countries such as India and China. Asia Pacific and Latin America are lucrative target areas for major key players of the surgical microscope market.

These include Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Topcon Medical Systems, Inc. (Topcon Corporation), Haag-Streit Group, Novartis AG, Takagi Seiko Co Ltd., and Global Surgical Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Steam Autoclave Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2016 - 2024

The global steam autoclaves market is marked by intense competitive rivalry and high entry barriers for new vendors, typical of markets featuring high consolidation, reports a recent study by Transparency Market Research (TMR). The oligopolistic market witnesses the dominance of companies such as STERIS, Getinge Group, and Johnson & Johnson, which collectively held close to two-third of the overall market in 2015.

The presence of a very small number of product manufacturers, preference of buyers for long-term contracts with steam autoclave devices manufacturers, and broad product portfolios have further reinforced the standing of leading vendors in the market. Product innovations, production of economic products, and strategies aimed at expansion in emerging regional markets could aid small vendors in the market carve out new growth channels in the near future. Other notable vendors operating amid intense competition in the global steam autoclave market are 3M Health Care, Belimed Group, CISA Group, Matachana Group, CISA Group, and SAKURA SI CO., LTD.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/steam-autoclave-market.htm

Rising Number of Surgeries and Hospital-acquired Infections Stimulate Adoption of Steam Autoclaves in Healthcare Settings

The vast increase in the number of surgical procedures undertaken across the globe every year has played a major role in the increased consumption of steam autoclaves globally in the past few years. The Centers for Disease Control and Prevention states that in U.S. alone, nearly 46.5 mn surgeries and around 5 mn endoscopies are performed every year. In other regions as well, such as the developing parts of Asia Pacific, which are marked by large population bases and flourishing medical tourism industries, a massive rise in the number of surgical procedures has been seen in the past few years.

Compounding the need for effective sterilization mechanisms in healthcare settings in addition to abovementioned factor is the concern regarding rising prevalence of nosocomial infections across the globe. These factors, in addition to the rising focus on patient safety, will allow the global steam autoclave market gain traction in the next few years.

Technological Advancements to Fuel Market’s Growth

The market has witnessed the introduction of several technologically advanced and increasingly effective products such as E-beam and gamma irradiation, which are further boosting the market’s growth prospects. High product compatibility and low cost of these new products are expected to help the global steam autoclave market gain significant momentum over the forecasting horizon.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3997

However, the increased usage of disposable devices across healthcare settings, which are not meant to be reused and require little or no sanitization over their usable life, could emerge as a major restraint for the overall growth of the market. Moreover, the imposition of excise duty taxes on the manufacturers of medical devices is also expected to hamper the overall profitability of steam autoclaves for vendors, thus resulting in increased product prices. This factor could also have a negative impact on the market’s growth prospects, especially in cost-sensitive developing regions.

In terms of popularity of product varieties available in the market, including traditional steam autoclaves and tabletop steam autoclaves, the market is again highly consolidated. The segment of traditional autoclaves accounted for a share of over 91% in the market in 2015. The segment is also expected to expand at the highest CAGR of 5.8% over the period between 2016 and 2024. North America was the leading regional market in 2015, with nearly 40% share in the market in terms of revenue in 2015.

On a whole, the global autoclave market was worth US$1.57 bn in 2015. Expected to rise at a healthy 5.7% CAGR from 2016 to 2024, the market is projected to touch US$2.57 bn by 2024.

This review is based on a latest market intelligence report published by Transparency Market Research, titled “Steam Autoclave Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Prenatal and New-born Genetic Testing Market is progressing at a CAGR of 26.9% within a forecast period of 2013 to 2019

Global Prenatal and New-born Genetic Testing Market: Snapshot

Prenatal and new-born genetic tests refer to the systematic diagnostic tests and screenings undertaken to determine the risk of certain genetic disorders in newborn children and fetuses in stages as early as eight to ten weeks of gestation. The use of a variety of screening and diagnostic tools for detecting chromosomal abnormalities and the risk of diseases such as Patau syndrome, Down syndrome, and Edward syndrome is increasing at a significant pace across the world.

The vast rise in prevalence of genetic abnormalities and late pregnancies are some of the key factors to have led to an increased demand for prenatal and new-born genetic tests across the globe. The vast advancements observed in diagnostic and screening technologies and the rise in awareness about genetic diseases are also considered crucial to the rising demand for genetic tests in children, both before and after birth. Transparency Market Research states that the market will exhibit a remarkable 26.9% CAGR over the report’s forecast period.

Read Full Report: http://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html

Diagnostic Techniques to Continue to Remain Preferred Option for Detecting Chromosomal Abnormalities

The prenatal and newborn genetic testing market can be broadly segmented into screening techniques and diagnostics techniques. Of these, the segment of diagnostic techniques, covering popular genetic testing methods such as fluorescence in-situ hybridization (FISH), array comparative genomic hybridization (aCGH), and polymerase chain reaction (PCR), accounts for a massive share of the market.

Diagnostic techniques are expected to retain their position as the leading contributor of revenue to the global prenatal and newborn genetic testing market over the forecast period, owing to their more effective and accurate results as compared to screening techniques. Of the key genetic diagnostic techniques available in the market, PCR techniques are expected to be the most preferred owing to their high efficiency and varied applications.

Of the key prenatal and newborn genetic screening techniques commonly used across the globe, including maternal serum screening (MSS) and non-invasive prenatal testing (NIPT), the segment of non-invasive prenatal testing is expected to lead the market for prenatal and newborn genetic screening techniques. This is owing to the fact that non-invasive screening techniques completely eliminate the risk of miscarriage associated with invasive tests such as Chorionic Villus Sampling (CVS) and amniocentesis.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1744

Emerging Markets to Present Most Lucrative Growth Opportunities

Presently, North America is the dominant market for the global prenatal and newborn genetic testing market, accounting for a massive chunk of the overall market. Apart from a large pool of highly-aware parents and a rising prevalence of genetic disorders in the region, the large number of companies operating in the diagnostics as well as screening sectors have also helped the prenatal and newborn genetic testing market strengthen its foothold in the region. Another developed region, Europe, is also a mature market for prenatal and newborn genetic testing.

However, in the next few years, the prenatal and newborn genetic testing market will witness the most traction across emerging regional markets such as Asia Pacific, and Middle East and Africa. The vast untapped opportunities in these regions and an encouraging rise in awareness about genetic testing, rising affordability, and increasing prevalence of genetic diseases will together contribute towards the healthy growth of the prenatal and newborn genetic testing market in these regions in the near future.

Some of the key vendors operating in the diagnostics field of prenatal and newborn genetic testing are Ariosa Diagnostics, Bio-Rad Laboratories, Perkin Elmer, and Agilent Technologies. Key vendors operating in the screening segment of prenatal and newborn genetic testing are Verinata Health and Sequenom, Inc.

Synthetic Biology Market - Recommendations for 2016; Emerging Trends and New Technologies Research 2013 - 2019

Global Synthetic Biology Market: Snapshot

Organisms engineered with novel techniques of synthetic biology are more affordable as it increases the use of genetically modified microorganisms for various industrial applications and cuts down the cost of research. This is leading to the greater utilization of synthetic biology technologies and products by researchers across the globe. The growth of the global synthetic market is backed by the intervention of government bodies, universities, and large organizations in synthetic biology research activities.

Furthermore, the rapid advancements in technologies are working in favor of the growth of the market. According to a report by Transparency Market Research (TMR), the opportunity for the global market for synthetic biologics was worth US$5.48 bn in 2016 and is anticipated to rise at a tremendous CAGR of 32.6% from 2013 to 2019, reaching a valuation of US$13.37 bn by 2019.

Read Full Report: http://www.transparencymarketresearch.com/synthetic-biology-market.html

Demand for Synthetic Biology Techniques to Remain High in Healthcare Sector Due to Rising Prevalence of Chronic Diseases

On the basis of application, healthcare will continue to account for the lion’s share of the overall market revenue throughout the forecast period. The rapidly growing global population along with the increasing incidence of chronic and infectious diseases is augmenting the growth of the segment. Synthetic biology has the potential to offer cost-effective and highly efficient drugs and vaccines with low side effects and enhanced nutrition. These drugs and vaccines can be used for the treatment of various diseases such as AIDS, cancer, malaria, and other infections. The agriculture segment is estimated to expand at a phenomenal CAGR of 52.5% during the forecast period owing to the ever-rising demand for food coupled with the declining availability of agricultural land.

Based on technology, genome engineering will continue to dominate the market until 2019. The technology is being increasingly adopted due to the fact that it helps in modifying a specific area of DNA, thereby offering better reproducibility. However, the biological components and integrated systems segment is poised to outpace other segments, progressing at a CAGR of 43.0% during the same period. The growth of this segment can be attributed to its potential of reducing the cost of producing large-scale biofuels and medicines.

North America to Outperform Europe Owing to Increasing Research and Development Efforts

Europe was the leading regional market in terms of revenue in 2016. The increasing government participation and funding for the development of synthetic biology are driving the growth of the region. Moreover, the growing applications of this technology in the field of health, energy, environment, and other areas are contributing to the growth of the region. However, the region is expected to lose its dominance to North America by the end of the forecast period.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421

The growth of the North America region can be attributed to the positive initiatives by government and private organizations to promote synthetic biology research activities. The rising scientific research and development of new technologies are expanding the scope for the development of synthetic biology in the region. Furthermore, the domicile of a large number of key players offers North America an edge over other regions. The region is anticipated to represent 46% of the overall market revenue by 2019.

On the other hand, Asia Pacific is likely to rise at a noteworthy CAGR of 34.2% during the same period. The immense growth potential in this region is attracting the support of many international organizations for the development of synthetic biology. The burgeoning demand for high-quality nutrition and cheap medicines among people is surging the demand for synthetic biology techniques and thus fuelling the market in the region. Some of the prominent players in the global synthetic biology market are Gevo Inc., Bristol Mayer, DSM, Life Technologies, DuPont Inc., LS9 Inc., Genomatica Inc., and Amyris Inc.

Biodegradable Stents Market grows with growing prevalence of peripheral and coronary artery diseases

The competitive landscape in the global biodegradable stents market is quite consolidated as major players in the market hold a massive chunk. In 2015, Abbott Laboratories, Boston Scientific, Inc., and Biotronik led the pack with a 61.5% share in the global market. The unwavering focus of these companies on expanding their business in newer territories has enabled them to dominate the global market. In the coming years, the players are expected to invest in advanced and sophisticated products to offer better products to the overall healthcare industry.

According to the research report, the global biodegradable stents market is anticipated to be worth US$1.7 bn by 2024 as compared to US$18 mn in 2015. During the forecast years of 2016 and 2024, the global market is expected to expand at a CAGR of 30.1%.

Europe Emerges as Leading Regional Market Backed by German Demand

The two types of stents available in the global biodegradable stents market are coronary artery stents and peripheral artery stents. Of these, the coronary artery stents are expected to progress at a CAGR of 30.9% during the forecast period. The high incidence of coronary artery diseases is expected to drive this segment in the coming years.

Read Full Report: http://www.transparencymarketresearch.com/biodegradable-stents-market.html

In terms of regions the global market is divided into North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The report indicates that Europe will emerge as the dominant segment in the global market in the coming years. This regional market is expected to surge at a CAGR of 27.2% during the forecast period. Germany will lead the Europe biodegradable stents market in the coming few years.

Rise in Cardiovascular Diseases Spikes Demand for Biodegradable Stents

The Centers of Disease Control and Prevention (CDC) states that coronary artery diseases are responsible for 370,000 deaths across the U.S. every years. The global biodegradable stents market has been growing against the backdrop of high incidence of cardiovascular diseases, which are related to coronary artery diseases. The market is also being driven by the high prevalence of chronic conditions and rising geriatric population, which is prone to cardiovascular disorders. “The growing preference for stenting procedures for treating coronary artery diseases over bypass surgeries is also anticipated to boost the sales in the global market,” estimates the lead author of this research report. This trend is likely to be a key trend in the market as stenting reduces complications, assures better success rate, fastens recovery time, and costs less.

Bare metal stents (BMS) and drug eluting stents (DES) continue to remain in the artery long after it has eluted the drug. This can lead to thrombosis, in-stent restenosis, and other complications, which can require surgical removal of the stent. Thus, use of biodegradable stents are remarkable safer as they get completely absorbed in the artery soon after the drug is eluted. This factor has won the biodegradable stents incredible traction over the past few years.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12464

Unaffordability of Biodegradable Stents Dissuades Patients

Although the global biodegradable stents has a noteworthy CAGR, the market is likely to suffer due to the high cost of the products. Thus, the advantages of biodegradable stents are getting stymied due to their unaffordability. The premium pricing of these stents is expected to restrain the overall market’s growth in the coming years. Furthermore, the slow adoption rate of these stents in regions and countries where medical awareness is relatively low is also hampering the progress of the global market.

This review is based on Transparency Market Research’s report, titled “Biodegradable Stents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024.”

Biomedical Refrigerators and Freezers Market: Plasma Freezers and Blood Banks to Contribute Majorly to Market Revenue

Transparency Market Research forecasts that the global biomedical refrigerators and freezers market will expand at a healthy CAGR of 4.2% over the period between 2016 and 2024. The market, which held an opportunity of US$2.91 bn in 2015, is expected to rise to US$4.28 bn by 2024.

The rising prevalence of a number of chronic and infectious diseases, increasing global demand for personalized drugs, and the promising pace of technological developments across healthcare infrastructures in emerging economies are cumulatively driving the increased adoption of biomedical refrigerators and freezers globally. The steady rise in the number of blood banks in developing and developed regions combined with government initiatives aimed at raising awareness about blood donation have also favored the sustainable growth of the market in the past few years.

Read Full Report: http://www.transparencymarketresearch.com/biomedical-refrigerators-freezers-market.html

In the years to come, stringent emission regulation norms and rising awareness about the harms of greenhouse gases emitted from conventional refrigeration systems to the environment will compel product manufacturers to design greener products. Companies are surely coming to terms with the several changes aimed at fortifying this switchover, such as worldwide bans on refrigerants such as hydrofluorocarbons (HFCs). As a result, more green refrigerators and freezers will enter the biomedical industry in the next few years.

Plasma Freezers to Retain Dominant Stance in Global Market

Of the key varieties of refrigerators and freezers used in the biomedical industry, including plasma freezers, shock freezers, ultra-low temperature freezers, blood bank refrigerators, and laboratory/pharmacy refrigerators and freezers, the segment of plasma freezers presently dominates the market. The segment accounted for a share of nearly 29% in the market in 2015. The vast rise in demand for fresh frozen plasma and rising number of apheresis procedures across the globe will likely aid the segment continue dominating the market across the forecasting horizon as well.

The rising global demand for blood transfusion and a vast rise in the number of technologically advanced blood banks across the globe has also resulted in the heightened demand for plasma freezers globally. In terms of rate of expansion, however, the segment of laboratory/pharmacy/medical freezers will outpace the segment of plasma freezers through 2024. The segment of laboratory/pharmacy/medical freezers will exhibit a 5.49% CAGR from 2016 to 2024.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4666

Asia Pacific to Present Most Promising Growth Opportunities; North America to Remain Key Contributor

Rising geriatric population, rising investments towards technological advancements in healthcare infrastructure, and the flourishing medical tourism industry will collectively lead to vast growth opportunities for the global biomedical refrigerators and freezers market in in Asia Pacific in the next few years. The market will expand at the fastest CAGR of 5.84% among other key regional markets through 2024. The region is expected to hold an 18% share in the global market by 2024.

However, North America will continue to hold the largest share in the market and witness only a slight drop in its share in the global market by 2024. North America presently leads the market, accounting for a 52% share in market’s overall valuation in 2015.

The region holds a dominant position in the global market on account of the highly developed healthcare infrastructures, the presence of a large number of world’s leading biomedical companies, and the vast life sciences research activities undertaken every year. The introduction and high rate of adoption of technologically advanced products such as RFID-enabled equipment, multiple compressor equipment also favor the overall growth of the biomedical refrigerators and freezers market in North America.

Vendors Need to Focus on Development of Economic Products

The market features intense competition, which has further soared owing to the introduction of technologically advanced and innovative products at a sustained pace in the market. High R&D investments have compelled international companies to increase costs of products, somewhat limiting their appeal to only to the developed regions. This factor has worked well in favor of regional players, especially the ones operating in developing cost-sensitive economies such as Latin America and Asia Pacific.

Some of the leading vendors in the market are Haier Biomedical, Eppendorf AG, Aegis Scientific, Inc., Leibherr Group, Terumo Corporation, Philipp Kirsch GmbH, Panasonic Healthcare Co., Thermo Fisher Scientific, Inc., and Helmer Scientific.

Computer Aided Detection Market size and Key Trends in terms of volume and value 2016-2024

Computer aided detection (CAD) is a clinically established tool that helps in the diagnosis or detection of cancers, and cardiovascular and neurological diseases. These systems assist physicians to decrease false negative rate, detect cancer at early stages, reduce mortality rates caused due to cancer and other diseases, and improve inter and intra reader variability. Additionally, CAD systems are extensively used to help physicians in numerous tasks that include providing a second opinion to the diagnostic and detection outcomes and automatically recognizing all non-calcified lesions doubted of malignancy at images. A CAD system helps in diagnosis, detection, and risk assessment. The purpose of using a computer and CAD tools is to help in medical image diagnosis. Technologically advanced CAD systems provide a moderately trained physician the same diagnostic skills as an experienced radiologist. CAD has also been used to increase the sensitivity of diagnostic imaging in medical investigation and differential diagnostics.

This research study analyzes the market for computer aided detection in terms of revenue (US$ Mn). The market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. The report also includes key market dynamics, such as drivers, restraints, and opportunities, affecting the demand for computer aided detection products globally and country wise. Comparative analysis has also been included in the executive summary for each region of 2016 and 2024.

Read Full Report: http://www.transparencymarketresearch.com/computer-aided-detection.html

The report provides in-depth analysis of the computer aided detection market. The stakeholders of this report include companies engaged in the manufacture of CAD products used along with medical imaging equipment in screening of cancers and other diseases. The executive summary section is included in this report to provide a snapshot of the market. It summarizes the market size, trends, and competition in different regions.

The market overview section of this report analyzes market dynamics such as drivers, restraints, and opportunities that influence the computer aided detection market in the current and future scenario. Market share analysis is provided to signify percentage share of the major players operating in the computer aided detection market. These factors will help the market players to chalk out business strategies and plans to strengthen their positions in the global market.

Based on application, the computer aided detection market has been segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, liver cancer, other cancers, and other disease. In terms of imaging modality, the market has been segmented into mammography, magnetic resonance imaging, ultrasound imaging, tomosynthesis, CT, and others.

View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1442

In terms of region, the computer aided detection market has been segmented into four major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries such as the U.S., Canada, Germany, the U.K., Japan China, Russia, Brazil, Mexico, and South Africa have been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the market in various regions has been provided in this section.

The report provides market estimation of the computer aided detection market in terms of revenue (US$ Mn) for all the segments and sub segments, with CAGR % for the period from 2016 to 2024, considering 2015 as the base year. Furthermore, the report incorporates market attractiveness analysis by product category that depicts the most attractive product segment in the global market during the forecast period from 2016 to 2024.

This report also includes a recommendations section that will assist new companies to establish their presence and existing market players to expand their market shares in the computer aided detection market. The report concludes with the company profile section, which includes company overview, financial overview, product portfolio, business strategies, and recent developments of market players. Key players profiled in the report include Agfa-Gevaert N.V., Fujifilm Medical Systems USA, Inc., GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Samsung Medison Co. Ltd, and Philips Healthcare.

Needle Free Drug Delivery Devices Market size and Key Trends in terms of volume and value 2015-2023

This report on the needle free drug delivery devices market analyzes the current and future scenario of the global market. Large number of chronic pain and diabetes sufferers is increasing the usage of needle free drug delivery devices. Less pain and consistency in drug delivery are the major drivers of the global needle free drug delivery devices market.

The needle free drug delivery devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global needle free drug delivery devices market.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/needle-free-delivery-devices-market.htm

Based on technology, the market has been segmented into jet injectors and competing needle-free technologies. The competing needle-free technologies segment has been further divided into novel needle technology, inhaler technology, and transdermal patch technology. Novel needle technology includes micro-needle and pen needle. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on application, the needle free drug delivery devices market has been segmented into five major categories: vaccine delivery, pain management, insulin delivery, pediatric injections, and others. Other applications of needle free drug delivery devices include angina, hypertension, and other medical conditions. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=447

Geographically, the global needle free drug delivery devices market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, and Rest of Europe), Asia Pacific (Japan, China, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global needle free drug delivery devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Zogenix, Inc., 3M Health Care, Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, and Pharmajet, Inc.

Operating Room Equipment Market: Business Challenges, Emerging Technologies & Competitive Landscape

The operating room equipment market report evaluates each of the segments and its sub-categories in detail for market trends, recent developments, outlook, and opportunities. The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that currently have strong impact on the global operating room equipment market and could influence the market in future as well. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition between leading market players operating across the globe. All these factors would help market players to take strategic decisions in order to strengthen their market positions and increase their correspondent market shares.

The recommendations section included in the report would assist existing market players in targeting all major stakeholders in this industry such as companies and hospitals. The report also profiles major players in the global operating room equipment market based on various attributes such as company details, business overview, financial facts, business strategies and recent developments.

Read Full Report: http://www.transparencymarketresearch.com/operating-room-equipment-market.html

The operating room equipment market report analyzes the current and future prospects of the global market. The operating room equipment market comprises movable imaging systems, biomedical systems, endoscopes, anesthesia systems, operating tables, operating room lights, surgical imaging displays, operating room integration systems, surgical booms, and microscopes. The growth of the overall market is due to rise in number of hospitals, growing number of ambulatory surgical centers, surge in demand for hybrid operating rooms, growing number of regulations for operating room equipment, and increase in number of geriatric population coupled with high number of surgeries worldwide. Globally, the operating room equipment market has been experiencing steady growth and the trend is expected to continue during the forecast period from 2015 to 2023.

Based on product type, the operating room equipment market has been segmented into movable imaging systems, biomedical systems, endoscopes, anesthesia systems, operating tables, operating room lights, surgical imaging displays, operating room integration systems, surgical booms, and microscopes. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1674

Additional information, such as recent developments in operating room equipment, market dynamics, and value chain analysis, in the market overview chapter provides details to assist new and existing players to venture and explore latent market opportunities in the near future. This report provides in-depth analysis of the global operating room equipment market. The stakeholders for this report include companies involved in the research and development and application. In order to provide a snapshot of this market to stakeholders, this report includes an executive summary section, which summarizes the market size, trends, and competition for different regions.

Major drivers of demand and growth of the operating room equipment market include growing number of ambulatory surgical centers, product innovations driven by advances in technology, rising demand for hybrid operating room, and increase in the number of surgeries. Apart from this, innovations related to patient handling techniques will propel the operating room equipment market in the next few years. Major restraints of the market include high cost of operating room equipment. However, the report also highlights various opportunities that are expected to boost market growth during the forecast period.

The operating room equipment market report also includes recommendations section that will assist new companies to establish their presence and existing players to expand their market shares. Key players in the operating room equipment market include Allen Medical (Hill ROM), GE Healthcare, KARL STORZ GmbH & Co. KG, Mizuho OSI, Maquet Holding B.V. & Co. KG (Getinge AB), Olympus Corporation, Philips Healthcare, Siemens Healthcare, Skytron, LLC, Steris Corporation, Stryker Corporation, and TRUMPF GmbH + Co. KG.

Dental Laboratories Market to 2023: Trends, Business Strategies and Opportunities with Key Players Analysis

Global Dental Laboratories Market: Overview

The global market for dental laboratories is undergoing a widespread transformation. The rising prevalence of oral disorders, coupled with the growing awareness regarding oral care and hygiene, is driving this market substantially. In addition to this, the increase in cosmetic surgeries of teeth, fueled by the surging interest of consumers towards personality grooming, is expected to support this market considerably over the forecast period.

According to Transparency Market Research (TMR), the global market for dental laboratories stood at US$12.9 bn in 2014. Rising at a CAGR of 4.90% during the period from 2015 to 2023, the market is likely to reach US$20.2 bn by the end of 2023.

Read Full Report: http://www.transparencymarketresearch.com/dental-laboratories-market.html

In this research report, the worldwide market for dental laboratories has been studied with a microscopic view in an attempts to provide a detailed market assessment on the basis of its past performance and its present status. The recent prominent trends and the lucrative growth opportunities within this market have also been examined thoroughly to identify its future status in this research study.

Global Dental Laboratories Market: Trends and Opportunities

The rise in the aesthetic consciousness of consumers across the world is having a significant influence on the global market for dental laboratories. The substantial rise in the disposable income of people has boosted their spending power, fueling their interest in facial beauty, especially in their dental care. This, as a result, is adding considerably to the worldwide dental laboratories market.

Global Dental Laboratories Market: Geographical Analysis

On the basis of geography, the global market for dental laboratories is spread across North America, Asia Pacific, Europe, and the Rest of the World. The U.S. and Canada are the key domestic markets for dental laboratories in North America. The Europe market for dental laboratories stretches across Italy, the U.K., France, Germany, Spain, and the Rest of Europe. Japan, China, and the Rest of Asia Pacific drives the Asia Pacific market while Latin America and the Middle East and Africa are the main regional markets in the Rest of the World.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2320

Europe has acquired the leading position in this market and is closely followed by North America. The increasing number of community-based oral health programs, conducted across Europe, which focus on delivering preventive treatments, increasing awareness, and improving patient education about various dental procedures and artificial products, has contributed significantly to the growth of the Europe market for dental laboratories. Researchers expect this regional market to remain on top over the next few years.

Asia Pacific, on the other hand, is expected to present attractive growth opportunities to market players in the years to come. The increasing trend of dental tourism and the substantial surge in the export demand for periodontics, orthodontic, bridges, crowns, and implants in emerging economies, such as India and China, are projected to propel the Asia Pacific dental laboratories market in the next few years.

Companies Mentioned in the Research Report

Sirona Dental Systems, Henry Schein Inc., Patterson Companies Inc., 3M Health Care, Keating Dental Arts, Modern Dental Laboratory Co. Ltd., Institut Straumann AG, Shofu Inc., National Dentex Corp., Danaher Corp., Yenadent Ltd. Sti., Dentcare Dental Lab, and Zimmer Biomet Holdings Inc. are some of the leading players in the global market for dental laboratories.

Nebulizers Market: Large Participant Pool Makes for Fragmented Competitive Landscape

A nebulizer is an electrically powered or battery operated instrument that converts liquid medication into mist. Nebulizer is one of the preferred choices for the treatment of asthma, cystic fibrosis (CFTR) and COPD (chronic obstructive pulmonary disease). This facilitates penetration of the medicine into the lungs of patients when inhaled through the mouth or a face mask. The nebulizers market in India is dominated by various devices powered by electric current and rechargeable batteries. Increasing prevalence of various respiratory disorders such as asthma, COPD, and CFTR coupled with rising geriatric population and deteriorating air quality in major cities of India fuel the growth of the nebulizers market in India.

This research report explains various advancements occurring in this market and analyzes the nebulizers market in India by products and geography. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments that are provided in the report. Moreover, executive summary comprises waterfall chart representing the nebulizers market in India by type in terms of INR Mn in 2014 which is drawn on the basis of most attarctive segment of the market. Comparative analysis has also been included in the executive summary that demonstrates the percentage market share of each segments in 2014 and 2023 respectively.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/india-nebulizers-market.htm

This report provides in-depth analysis of the nebulizers market in India. The stakeholders for this report include companies involved in the manufacture of nebulizers, kits and accessories and supply to to the hospitals and homes. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different zones of India. The market overview section of this report analyzes market dynamics such as drivers, restraints and opportunities that influence the nebulizers market in the current and future scenario. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the nebulizers market in India. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in India.

Based on the product, the nebulizers market in India has been segmented as pneumatic nebulizer, ultrasonic nebulizers, mesh nebulizer and nebulizer kits. Pneumatic nebulizer comprises pressurized gas supply that assists in pushing medication toward the mouth. Compressed gas is delivered through a jet (valve) that creates negative pressure on the medication tank to release the medication. An ultrasonic nebulizer uses electric current to produce high frequency vibrations in a container of fluid (medications) to break up the fluid into aerosol particles. Mesh nebulizers create vibrations (piezo) that enable the flow of liquid formulation (medicine) through a fine mesh (aperture plate) to develop aerosol medication.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10655

Region wise, the nebulizer market in India has been differentiated into five major regions: North Zone, South Zone, East Zone, West Zone, and Central/ Zone. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the India nebulizers market in various regions has been provided in this section. The report provides market estimation of nebulizers market in India in terms of revenue (INR Mn) for all the segments and sub segments with CAGR % for period 2015 to 2023, considering 2014 as the base year. The report also provides the volume of nebulizers for all the segments and sub segments with CAGR % for period 2015 to 2023. Furthermore, the report incorporates market attractiveness analysis by product category that depicts the most attractive product segment in India during the forecast period from 2015 to 2023.

This report also includes recommendations section that will assist new companies in establishing their presence and market players in expanding their market share in the nebulizers market in India. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Omron Healthcare, Philips Healthcare, CareFusion Corporation (BD), Nuilfe, Bhasins and Sons, Respirotec are among others.

Body Screening Market: Regional markets, technology, types, and applications

Body screening is a specialized method of detecting any hidden objects within a person’s clothes by creating an image of a person’s naked body without any physical contact or without physically removing the clothes. Body screening is done through body scanners. Military wave technologies are used by these body scanners in order to see through the clothes of a person. Globally, this method is gaining popularity due to increasing concerns about security fueled by an alarming rise in global terrorism.

The global body screening is expected a significant growth during the forecast period. This is mainly driven by a rise in drug trafficking, illegal migration, and terrorism.

This method is increasingly being adopted in train stations and airports all over the globe, primarily due to rising threat of terrorism and for aviation security. Moreover, the stringent rules and policies undertaken by various governmental bodies worldwide are driving the growth of the market. For instance, the bill passed by the U.S government called S.A.F.E.R A.I.R Act makes body screening mandatory in all airports.

In the face of rising instances of in-flight detonation and fight hijacking, body screening helps in improving the security framework of airports. The ability to detect a wide range of threats, including explosives, is propelling the demand for body screening. Commercial airports are also engaging in making significant investments in body screening systems to adequately address the burning issue of drug-peddling.

Read Full Report: http://www.transparencymarketresearch.com/body-screening-market.html

One of the major advantages of body screening is the reduced time taken to screen passengers. This gives body screening an upper hand over the conventional pat down approaches, which are both uncomfortable and time consuming. Growing interest in full body screening worldwide is spurring intensive research and development efforts to bring forth machines that are image free and result in less radiation.

Despite all the advantages, full body screening is controversial, as it easily raises individual privacy issues. Critics claim it to be in violation of human rights, unreasonable, and illegal. These factors are expected to restrain the growth of the market for body screening to some extent during the forecasted period.

The market is segregated on the basis of application, technology, system, and geography. By application, the global body screening market is segmented into homeland security, defense, and commercial. Homeland security is further sub-segmented into applications in seaports, airports, and security of VIPs. Defense is sub-segmented into applications in high security zones, military premises, and border crossing controls.

On the basis of technology, the global body screening market is characterized as digital tape measurements, white light patterns, laser scanners, 3D body scanners, and image modeling & processing.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18020

By system, the market is segmented into X-ray systems, millimeter-wave, and backscatter.

Lastly, on the basis of geography, the global body screening market is segmented into North America, Asia Pacific (APAC), Europe, Middle East & Africa (MEA), and Latin America. North America holds a significant share of the global body screening market mainly due to the strict steps taken by the U.S government with respect to body screening in airports. The growth of the body screening market in Europe is expected to be limited during the forecast period due to the ban imposed on full-body scanning in the countries of the region. On the other hand, the growth of the body screening market in emerging economies of Latin America and Asia Pacific is estimated to be significantly fast due to increasing security concerns, rise in the number of low cost carriers, expansion of the tourism industry, and booming air travel.

The key players operating in the global body screening market include Westminster International Ltd. (U.K), Tek84 Engineering Group LLC (U.S), Smiths Detection (U.K), Scan-X Security Ltd. (U.K), Rapiscan Systems (U.S), Nuctech Co. Ltd. (China), L-3 Security And Detection Systems (U.S), Digital Barriers PLC (U.K), Braun And Company Limited (U.K), American Science and Engineering (U.S), and ADANI Systems (Belarus).

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Multiplexed Diagnostics Market: Bolstered Funding for Genomics to Bode Well for Growth, predicts TMR

A handful of players dominated the otherwise fragmented global multiplexed diagnostics market in 2015. Thermo Fisher Scientific, Abbott Laboratories, and Agilent Technologies were the leaders of this market for 2015, with a collective share of 59.5% in terms of value. The market is defined by the presence of these few leaders and then the presence of a large number of small-scale and medium-scale enterprises that hold minor shares. The leaders of the global multiplexed diagnostics market in 2015 all showed a diverse product portfolio, the possession of advanced tech, and a wide area of regional presence.

In a research report recently published by Transparency Market Research, the global multiplexed diagnostics market is expected to witness a high degree of competition over the coming years. This fact is primarily concluded from the high volume of smaller players in the market that are eyed by the fewer, larger ones in terms of partnerships, mergers, and acquisitions. Although the volume of smaller players in the global multiplexed diagnostics market currently is very high, the scope for new entrants is much lower than expected, due to the need for acquiring patented technologies and the establishment of sizeable manufacturing facilities, both of which can eat up a large contingent of a company’s capital, leaving very little to spend on building feasible distribution networks. The global multiplexed diagnostics market is expected to be valued a little over US$6.0 bn by the end of 2016. After showing a consistently optimistic CAGR of 20.3% on its revenue from 2016 to 2024, the market is expected to reach US$26.36 bn by the end of 2024.

Read Full Report: http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html

Equipment Automation in Full Swing, Drives Demand for Multiplexed Diagnostics

“Tech automation using multiplexed diagnostics has so far been a blessing for scientists trying to generate a larger volume of sample results at lower costs. This forms the primary driver for the global multiplexed diagnostics market today. Players in the market are involved in multiple aspects of the healthcare industry in a similar manner. For instance, the automation of PCR amplification can be done using multiplexed diagnostic technologies, and can help users lower the rate of user-intervention required and the cuts down the overall hands-on efforts needed to get the program to execute. At the same time, this equipment automation can also allow a higher throughput, save time in processing and considerably reduce manual labor required, consequently cutting down the chances for errors,” states a TMR analyst.

The global multiplexed diagnostics market also finds a significant growth rate from the high priority funding that the field of genomics is currently receiving. The research community for multiplexed diagnostics has been able to avail this funding storm.

Multiplexed Diagnostics Assay a Costly Affair for Many

Multiplexed diagnostics is still a new concept for the healthcare industry and as with many nascent stage markets, solutions and products from it can be unaffordable for several small-scale and medium-scale clients. Multiplexed diagnostics assay tests are relatively very expensive when compared to single-plex assays tests, especially in terms of the initial investment required for the equipment.

“Despite its high costs, players in the global multiplexed diagnostics market can expect a booming demand in research and development efforts on the current applications for multiplexed diagnostics, thus providing them with ample opportunities over the coming years,” adds the analyst.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1719

The information presented in this review is based on a Transparency Market Research report, titled, “Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Life Science and Chemical Instrumentation Market: Historical, current, and projected size of the market from the standpoint of both value and volume

Global Life Science and Chemical Instrumentation Market: Overview

With investments in clinical research progressively rising, spending on instrumentation used for analytical chemistry is expected to rise continually as well. Analytical chemistry has proven useful in studying the composition of materials to find new applications for them or to modify their composition as desired. This end cannot possibly be met without the use of proper life science and chemical instrumentation. The global market for life sciences and chemical instrumentation is thus looking at a promising future ahead. TMR projects a positive outlook for the global life science and chemical instrumentation market through the forecast period. The market is expected to register a high single-digit CAGR.

From determining how safe a food sample is to analyzing DNA to discovering new drugs for chronic diseases, the use of life science and chemical instrumentation are myriad. The market is thus expected to fare well thanks to its many end users and application areas. This aspect will keep growth a constant in the life science and chemical instrumentation market.

The report on the global life science and chemical instrumentation market evaluates and prioritizes the factors that will influence its growth over the report’s forecast period. By meticulously segmenting the market on the basis of type of technology, end use, application, and geography, TMR’s analysts are able to dive deep into the present dynamics of the market and emerge with data that can aid prudent decisions. A holistic overview of the prevailing competitive environment in the market makes this report a valuable tool for tracking the strategies that competitors are expected to adopt.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11933

Global Life Science and Chemical Instrumentation Market: Drivers and Restraints

With governments across the world setting up incubation programs and special economic zones for companies in fields such as biotechnology and pure chemistry, the demand for life sciences and chemical instrumentation is expected to continually rise. Moreover, regulatory authorities in emerging countries such as Brazil, India, China, and Russia are now watching the F&B and pharma industries more closely in the wake of food scandals and pharmaceutical product recalls. This will compel companies to adhere to the highest quality standards, which will indirectly lead to higher sales of life science and chemical instrumentation products.

The cost of developing and marketing such instruments, however, can be a stumbling block for many market players. With companies naturally passing on costs to the consumers, the latter may be prompted to find more affordable alternatives, thwarting the growth plans of market players.

Global Life Science and Chemical Instrumentation Market: Segmentation

The most common uses of life science and chemical instrumentation market are seen in healthcare research agencies, contract research organizations, pharmaceutical and biotech entities, clinical and diagnostic laboratories, and academic research institutions. It is primarily the diagnosis technologies in question that determine the nature of chemical and life science instrumentation to be used.

Based on the area of usage, the life science and chemical instrumentation market can be segmented thus: Electrophoresis, chromatography, laboratory automation, DNA sequencers and amplifiers, flow cytometry, spectrometry, and microarrays. The demand for DNA amplifiers and sequencers is expected to show an upswing on the back of rising investments in biotechnology, which have dramatically risen in the post-recession phase.

The outlook for the chromatography segment, too, is positive. This can be ascribed to the growing uses of chromatography-coupled with a remarkable spike in UHPLC chromatography-across diverse verticals. Companies such as Agilent, Shimadzu, and Waters Corporation are at the forefront of innovation, enabling them to capture a larger section of the market in this space. The report also expects a healthy upswing in the demand for instruments such as fume hoods, laboratory balances, and centrifuges.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=11933

The applications of life science and chemical instrumentation devices include, but are not limited to: Forensic technologies, biotechnology, environment, agriculture, chemicals, food and beverage, and pharmaceuticals. The biotech and pharmaceutical sectors will be the growth engine for life science and chemical instrumentation market by application. Intensive research programs in developed nations will indirectly fuel sales of life science and chemical instrumentation. The trend is only just beginning to take shape in developing nations, and could soon be a high-impact driver.

By geography, the global life science and chemical instrumentation market has been divided into: North America, Asia Pacific, Europe, MENA, and Rest of the World.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Traveler’s Diarrhea Market: Enterotoxigenic Escherichia coli is the most common causative agent

Traveler’s Diarrhea Market: Overview

Traveler’s diarrhea refers to intestinal and stomach infection and occurs due to unsanitary conditions during handling of food. This disorder is characterized by frequent abdominal cramps resulting in loose stools and is usually caused by consumption of contaminated water or food. Travelling from one place to another where the sanitary conditions, social conditions, climate and other factors are different and hence presents high risk of developing traveler’s diarrhea.

This is one of the most common condition affecting travelers every year, for example according to data enumerated by Centers for Disease Control and Prevention (CDC), around 20% to 50% an estimated 10 million of the international traveler’s develop traveler’s diarrhea every year. This disorder occurs during the travel period or post return and also in some cases one can experience multiple episodes of diarrhea during one trip. Developing countries of Latin America, Middle East, Asia and Africa represent the areas for highest risk of contracting traveler’s diarrhea. Immunosuppressed individuals, young adults and individuals with inflammatory bowel disorders and diabetic patients constitute the highly susceptible patient population for contracting traveler’s diarrhea.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13433

Intensity of infection varies depending on the type of eating establishment. For instance, there is low risk of infection if the food is consumed in private homes and poses high risk of infection in the food from the street vendors. Nausea, vomiting, fever, frequent defecate and abdominal cramps are some of the common symptoms of traveler’s diarrhea. Most of the cases are benign and resolve quickly but sometimes sign and symptoms persist for several days and can be more severe in cases where it is caused by other organisms other than common bacteria. In these cases, prescription medicines are recommended for the treatment. Enterotoxigenic Escherichia coli is the most common causative agent of traveler’s diarrhea. Travelers can minimize the risk of developing traveler’s diarrhea by adopting several preventive measures such as use of bottled drinking water, avoiding consumption of raw or uncooked seafood and meat and raw fruits.

Consulting a doctor than self medication is preferred for the treatment of traveler’s diarrhea and especially relevant to pregnant women and children. There are several medications prescribed for the treatment of diarrhea. For example, Pepto-Bismol tablet shortens the duration of illness and decreases diarrhea. This drug is not advised to take for more than three weeks at a time as it results in certain side effects such as temporary blackening of stools and tongue, constipation, nausea and others. Also, the consumption of this is not recommended for the patients who have aspirin allergy, gout, renal insufficiency and who are already taking anticoagulants. Other treatment options are replacement of fluids and salts achieved by the intake of oral rehydration solutions such as oral rehydration salts (ORS).

Traveler’s Diarrhea Market: Segmentation

The market for traveler’s diarrhea can be analyzed by the various medications available for the treatment and the geographical landscape. Antimicrobial therapy is the most preferred one and fluoroquinolones are the most preferred. The geographical landscape elucidates the analysis of the market by four major geographies namely North America, Asia-Pacific, Europe and Rest of the World. In addition, factors such as side effects of the drugs, introduction of alternate therapies, and increased focus on preventive care would impact the market growth.

Furthermore, regulatory policies, marketing approvals for drugs and safety concerns would further influence the market growth. The major factors favoring the market growth are increasing cases of traveler’s diarrhea and growing tourism across the globe. On the other hand, factors such as side effects of the drugs and lack of accessibility to appropriate treatment might encumber the market growth.

Bayer AG, Johnson & Johnson, Merck & Co., Inc. and Novartis AG are some of the companies operating in this market.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.